Durect (DRRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DRRX Durect

Watchlist

1.3300
-0.0100-0.75%

Close Nov 8 16:00 ET

1.3300
0.00000.00%

Post 20:01 ET

41.28MMarket Cap-2180P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: Durect to Report Financial Results Post-market on November 13
Moomoo NewsNov 7 20:00 ET
Express News | DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
ReutersNov 6 16:45 ET
Durect Corp Annual Meeting Decisions and Shareholder Votes
TipRanksSep 26 17:00 ET
Durect Agreement on Larsucosterol Trial 'a Major Positive,' Says Northland
TipRanksSep 26 09:00 ET
Durect Analyst Ratings
BenzingaSep 26 06:38 ET · Ratings
Express News | DURECT Corp - Phase 3 Trial to Enroll 200 U.S. Patients
ReutersSep 25 08:00 ET

Comments

Jaguar8

Oct 16 15:46

Form 4

$Durect (DRRX.US)$

Jaguar8

Sep 25 07:06

NEWS

$Durect (DRRX.US)$
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
Type B meeting with FDA held under Breakthrough Therapy designation resulted in agreement on key aspects of Phase 3 trial design
- Single Phase 3 trial designed to enroll 200 U.S. patients with a 90-day survival primary endpoint;topline results expected within two years of trial initiation
- Protocol for Phase 3 trial builds on data from the AHFIRM Phase 2b tr...

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Trytosaveabit

May 21 07:02

News

$Durect (DRRX.US)$ Reuters· 1 min ago
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Cannabis & Hemp

Intraday-1.05%

DRRX Durect

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target